Navigation Links
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
Date:3/6/2008

7 33,007 Cost of products sold 5,447 3,253 15,864 9,943 Gross profit margin 13,715 9,007 43,003 23,064 Costs and expenses:

Research and development 11,572 6,066 32,492 23,826

Selling, general, and

administrative 11,503 8,997 46,603 37,357 Total costs and expenses 23,075 15,063 79,095 61,183 Loss from operations (9,360) (6,056) (36,092) (38,119) Interest income 655 615 2,141 1,879 Interest expense (1,151) (992) (4,270) (2,179) Net loss $ (9,856) $ (6,433) $ (38,221) $ (38,419) Net loss per common share,

basic and diluted $ (0.30) $ (0.25) $ (1.29) $ (1.48) Shares used in computing

net loss per common share,

basic and diluted 32,884 26,074 29,621 26,011

ISTA Pharmaceuticals, Inc.

Summary of Consolidated Balance Sheets Data

(in thousands)

(unaudited)

December 31, December 31,

2007 2006 Cash and short-term investments $ 46,140 $ 38,934 Restricted cash 2,400 5,600 Working capital 32,686 27,998 Total assets 71,716 59,743 Total stockholders' deficit (1,308) (4,559)


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
2. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
3. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
4. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
5. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
6. SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results
7. NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
8. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
9. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
10. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
11. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SAN DIEGO, Aug. 29, 2014  Pfenex Inc. ... in the development of high-value and difficult to ... business update and reported financial results for the ... "With the successful completion of our initial public ... advance our biosimilar product candidates, derived from our ...
(Date:8/29/2014)... are based on electrons, but one of the most ... i.e. circuits based on light (photons) instead of electrons. ... a stream of single photons and control their direction. ... attempts to achieve this control, but now scientists at ... steady stream of photons emitted one at a time ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 The ... $5.6 billion in 2019. It is expected to ... to 2019, and was valued at $1.8 billion ... by Transparency Market Research. , For more information ... http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, titled “Companion ...
(Date:8/29/2014)... 29, 2014 According to a new market ... global orthobiologics market was valued at USD 3,754.6 million in ... 5,519.9million in 2019at a CAGR of 5.9% from 2013 to ... and above is afflicted by bone and joint disorders, and ... 2020. This has and will continue to increase the demand ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
... Solutions, LLC, Santa Clara, CA, a manufacturer of ... Nova Biomedical, Waltham, MA, a world leader in ... TruBio(TM) plug-in for OPC connectivity between TruBio control ... de facto standard for data exchange between process ...
... CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... company focused on endocrine therapy and oncology, will announce ... results before market open on Wednesday, March 11, 2009. ... to discuss these results later that same day at ...
... Plants to Further Develop Plant Traits for BiofuelKINGSTON, ... (PPI), a global leader in agricultural and biofuel ... are pleased to announce that a project led ... in funding from SDTC. The funds will be ...
Cached Biology Technology:UPDATE: OPC Connectivity Between TruBio Software and Nova FLEX Analyzers 2Canadian Government Announces Funding for Leading Biotechnology Firm's Project 2Canadian Government Announces Funding for Leading Biotechnology Firm's Project 3
(Date:8/29/2014)... Davis have made some surprising discoveries about the ... immunodeficiency virus (SIV), the team found that specialized ... early responders to viral invasion and are the ... called interleukin-1 beta (IL-1β). , Though aimed ... of the gut epithelium that provides a barrier ...
(Date:8/29/2014)... Scientists at the Barshop Institute for Longevity and ... the UT Health Science Center at San Antonio, have ... the longest-lived rodent, the naked mole rat. , ... naked mole rats protects and alters the activity of ... proteins. , The factor also protects proteasome function in ...
(Date:8/29/2014)... little has been known about what genetic changes transform ... scientists, one of whom is a University of Montana ... genes controlling the development of the brain and the ... study was published Aug. 28 in Science ... online at http://www.sciencemag.org/ ., The domestication of animals ...
Breaking Biology News(10 mins):The early cost of HIV 2Factor in naked mole rat's cells enhances protein integrity 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
... DALLAS May 11, 2010 Microbiologists at UT Southwestern ... a potential target in cattle that could be exploited to ... strain of Escherichia coli . In the ... Proceedings of the National Academy of Sciences , researchers ...
... The car is not the only vehicle that can ... Engineering Technical School, Mikel Lejarza, Jose Ignacio Uriarte, Miguel ngel ... research team working on an innovative project: to have a ... and unmooring) using electric energy obtained from the movement of ...
... 2010) -- Cell-cell junctions are multi-molecular complexes that ... as barriers to permeability, and allow intercellular transport. ... Spring Harbor Laboratory Press, surveys current research on cell ... University) and W. James Nelson (Stanford University), both leaders ...
Cached Biology News:UT Southwestern researchers find mechanism that may stop E. coli from developing in cattle 2Project for sailing vessels to maneuver in ports using electric energy from wind 2Project for sailing vessels to maneuver in ports using electric energy from wind 3
KV beta.1 (Q-13)...
Preadipocyte factor-1 [Pref-1, DLK-1], C-terminal...
... 4 deuterium atoms at the 3, 3', ... for use as an internal standard for ... GC- or LC-mass spectrometry. PGE2 is one ... acid and one of the most widely ...
Deletions, insertions or substitutions. Mutations in plasmids of size up to 15 kb. Single or multiple mutations...
Biology Products: